Healthcare systems worldwide are under immense pressure to deliver cost-effective, value-based care to an aging population, often beset with complex lifestyle-related chronic illnesses.
Sustainability requires a shift in focus from episodic to continuous care, where patients monitor their health and co-manage their treatment remotely.
We help healthcare companies develop digital health solutions that leverage recent advancements in connectivity and data science for competitive advantage.
Smart connected devices
We have a proven track record developing both consumer and medical connected devices and establishing the infrastructure that allows our clients to harness their data.
Having developed the world's first single-chip Bluetooth solution – now used in over 70% of all smartphones – our more recent breakthroughs include the first 24/7 wrist-worn activity monitor, the first wireless pacemaker, the first wireless patient monitor and the first connected inhaler.
Digital health strategy
We provide strategic advice on long-term strategic roadmaps, business system integration, digital transformation and go-to-market strategies.
We can assist across the entire digital health journey including: creating compelling strategies and strong stories for investors; shaping the teams and partnerships needed to support digital services; rapid prototyping of service offerings; and roadmap innovation and development.
Interested in joining us?
Tech, tools & facilities
Anechoic test chamber
Our custom anechoic radio and antenna test chamber is a highly sophisticated 5m cube. Inside, we carry out automated three-dimensional measurement and visualization of wireless device behavior and test body-worn technology using body phantoms or real live test subjects. This helps us to understand and optimize real-word RF performance of products such as smart implants (including implanted telemetry), connected drug delivery devices and wearables.
Life science labs
Our suite of restricted Class II laboratories are specifically designed for handling and experimentation of pharmaceuticals, licensed substances, biological hazards and human samples in a controlled and regulated environment. Our instrumentation rooms are equipped with metrology, microscopy and product test equipment for rigorous verification and quality assurance of prototypes and products.
Our electronic and mechanical prototyping workshops allow us to produce technically credible prototypes that bring ideas to life and offer a powerful demonstration of their value. All while maintaining extremely high standards of quality that conform to ISO 9001, ISO 13485 and ISO 14001 regulations. Using the latest CNC and milling machines, lathes, welding gear and wire harness and cable assembly tools, we are able to produce parts very quickly and assemble full-scale working prototypes for testing and consumer trials.
Surgical innovation suite
Equipped to simulate clinical, home and office environments, this facility allows us to test concepts, evaluate prototypes and analyse workflows in a safe and confidential setting. It’s an invaluable tool for understanding and communicating the contextual implications of design decisions, while the ability to conduct quick-turnaround usability evaluations means we can efficiently progress design and development.
The Digital Greenhouse is our purpose-built AI research facility, specifically designed to discover, develop and test machine learning approaches in a fast, secure environment. The facility features an NVIDIA DGX-1 Deep Learning Supercomputer, a bank of machine learning computers, petabyte local storage and many teraflops of dedicated compute power.
Before athletes even thought about how technology could improve their performance, Harvard students Will Ahmed and John Capodilupo struck on an idea to revolutionise physiological monitoring for both professional and college athletes. Today their creation – WHOOP – is a global training phenomenon relied on by NFL footballers, Olympic athletes, PGA Tour golfers and an exploding number of consumers and weekend warriors.
This is the story of digital services innovation that is disrupting traditional markets while helping companies make their product offerings more sustainable, cost efficient and safe. At the heart of the story is a low-cost asset-monitoring sensing tag that is small, light and powerful enough be stuck just about anywhere. This core technology concept, now called DriveTag, is helping our client Sycada with its mission to prove that sustainability can go hand in hand with healthy ROI.
An empowering design solution addressing unmet needs
A major milestone, enabled by our breakthrough sensing technology.
News & insights
Cambridge Consultants announces its collaboration with MedTech Innovator, a world-leading non-profit start-up accelerator
Cambridge Consultants part of Capgemini, today announced its collaboration with MedTech Innovator Asia Pacific, the world’s leading non-profit accelerator of medical devices
Helius Medical Technologies’ groundbreaking PoNS device for short-term treatment of gait deficit due to multiple sclerosis has received marketing authorization from the U.S. Food and Drug Administration (FDA).
Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings.
- AI & Analytics
- Connectivity & IoT
- Digital health
- Signal processing
The what, why and how of connected medical implant development for personalized delivery of medicine
The medical implant industry is set to grow from $5bn in 2017 to $16.3bn by 2022. But there are tensions to understand and hurdles to overcome for innovators intent on taking advantage.
- Connectivity & IoT
- Digital health
- Product realisation
Join us live in San Diego, California on September 26-27 2022 for 2 days of innovative presentation, intelligent debate and targeted networking with business leaders in the pharmaceutical, biologics and device developments.
Partnership Opportunities in Drug Delivery (PODD) is back in person. On October 24, 2022, we gather in Boston, MA, with experts across pharma, biotech and the drug delivery industries for a two-day event focused on the latest formulation needs, trends and technologies impacting drug delivery, and the opportunities to improve therapies and extend the lifecycle of a drug. Harshal Shah, Global BioPharma Sector Head, Cambridge Consultants, will host a session focused on miniature active implants and the future of innovation in drug delivery.
Bringing together leading genomic researchers, healthcare professionals, and healthcare industry stakeholders to usher in a new era of precision medicine.
The 14th annual symposium is the highlight event of the Hamlyn Centre for Robotic Surgery, at Imperial College London. It provides a forum for international surgeons and engineers to network and share the latest developments in medical robotics, attracting world-leading scientists, engineers and clinical practitioners from a wide range of disciplines associated with medical robotics and surgery.